Signature Financial Management’s Gilead Sciences GILD Stock Holding History

Signature Financial Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-3,111	Closed	-$240K	–	144
2018 Q3	$240K	Sell	3,111 -63	-2%	-$4.76K	0.04%	137
2018 Q2	$224K	Hold	3,174	–	–	0.05%	147
2018 Q1	$239K	Buy	+3,174	New	+$252K	0.05%	142
2017 Q4	–	Sell	-5,908	Closed	-$425K	–	131
2017 Q3	$425K	Buy	5,908 +1,453	+33%	+$111K	0.13%	98
2017 Q2	$314K	Buy	4,455 +526	+13%	+$35K	0.1%	111
2017 Q1	$266K	Sell	3,929 -300	-7%	-$21.1K	0.09%	123
2016 Q4	$304K	Sell	4,229 -140	-3%	-$10.4K	0.11%	105
2016 Q3	$345K	Buy	4,369 +715	+20%	+$58.1K	0.14%	83
2016 Q2	$305K	Buy	+3,654	New	+$324K	0.14%	86

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Signature Financial Management's GILD Position: Q4 2018 in Review

Signature Financial Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 3,111 shares — an estimated $240K sold.

Signature Financial Management first reported a position in GILD in Q2 2016 and held it in 9 quarters. The position peaked at $425K in Q3 2017. 1,497 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Signature Financial Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Signature Financial Management sold 3,111 Gilead Sciences shares in Q4 2018, an estimated $240K.
Signature Financial Management first reported a position in Gilead Sciences in Q2 2016 and held it in 9 quarters.
Signature Financial Management's Gilead Sciences position peaked at $425K in Q3 2017.
1,497 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Signature Financial Management's 13F filing for Q4 2018, filed 13 Feb 2019.